Cerebrovascular Complications in Patients with Cancer

 

 Buy Article Permissions and Reprints

ABSTRACT

Stroke in the cancer patient is often caused by disorders of coagulation that are induced by the cancer, by cancer metastatic to the central nervous system, or by coagulation disorders or vascular injury due to cancer therapy. Nonbacterial thrombotic endocarditis in association with diffuse thrombosis of cerebral vessels is often the cause of cerebral infarction. Venous occlusion is most common in leukemic patients, but can also result from growth of solid tumor in the adjacent skull or dura. Chemotherapy administration is associated with a small risk of cerebral arterial or venous thrombosis. Radiation that is administered to the neck can result in delayed carotid atherosclerosis. Tumor embolization to the brain is a rare cause of stroke. Fungal septic cerebral emboli occur most commonly in leukemic patients who have undergone bone marrow transplantation. Hemorrhages occur in the brain parenchyma or the subdural and subarachnoid spaces and are most commonly caused by acute disseminated intravascular coagulation or metastatic tumor. Hemolysis from chemotherapy administration is a rare cause of brain hemorrhage. Careful clinical assessment, neuroimaging studies, measurement of coagulation function, and echocardiography are the most useful modalities to identify the cause of stroke.

REFERENCES

• 1 Lee A Y. Cancer and thromboembolic disease: pathogenic mechanisms.  Cancer Treat Rev. 2002;  28(3) 137-140
  CrossrefPubMedGoogle Scholar
• 2 Zhang Y-Y, Chan D KY, Cordato D, Shen Q, Sheng A Z. Stroke risk factor, pattern and outcome in patients with cancer.  Acta Neurol Scand. 2006;  114(6) 378-383
  CrossrefPubMedGoogle Scholar
• 3 Cestari D M, Weine D M, Panageas K S, Segal A Z, DeAngelis L M. Stroke in patients with cancer: incidence and etiology.  Neurology. 2004;  62(11) 2025-2030
  PubMedGoogle Scholar
• 4 Graus F, Rogers L R, Posner J B. Cerebrovascular complications in patients with cancer.  Medicine (Baltimore). 1985;  64(1) 16-35
  PubMedGoogle Scholar
• 5 Kim S G, Hong J M, Kim H Y et al.. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea.  Stroke. 2010;  41(4) 798-801
  CrossrefPubMedGoogle Scholar
• 6 Rogers L R, Cho E-S, Kempin S, Posner J B. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation.  Am J Med. 1987;  83(4) 746-756
  CrossrefPubMedGoogle Scholar
• 7 Reisner S A, Brenner B, Haim N, Edoute Y, Markiewicz W. Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entity.  J Am Soc Echocardiogr. 2000;  13(9) 876-881
  PubMedGoogle Scholar
• 8 Reagan T J, Okazaki H. The thrombotic syndrome associated with carcinoma. A clinical and neuropathologic study.  Arch Neurol. 1974;  31(6) 390-395
  PubMedGoogle Scholar
• 9 Collins R C, Al-Mondhiry H, Chernik N L, Posner J B. Neurologic manifestations of intravascular coagulation in patients with cancer. A clinicopathologic analysis of 12 cases.  Neurology. 1975;  25(9) 795-806
  PubMedGoogle Scholar
• 10 Raizer J J, DeAngelis L M. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients.  Neurology. 2000;  54(6) 1222-1226
  CrossrefPubMedGoogle Scholar
• 11 Edoute Y, Haim N, Rinkevich D, Brenner B, Reisner S A. Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients.  Am J Med. 1997;  102(3) 252-258
  CrossrefPubMedGoogle Scholar
• 12 Patchell R A, White III C L, Clark A W, Beschorner W E, Santos G W. Nonbacterial thrombotic endocarditis in bone marrow transplant patients.  Cancer. 1985;  55(3) 631-635
  CrossrefPubMedGoogle Scholar
• 13 Santoro N, Giordano P, Del Vecchio G C et al.. Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study.  J Pediatr Hematol Oncol. 2005;  27(3) 153-157
  CrossrefPubMedGoogle Scholar
• 14 Masjuan J, Pardo J, Callejo J M, Andrés M T, Alvarez-Cermeño J C. Tamoxifen: a new risk factor for cerebral sinus thrombosis.  Neurology. 2004;  62(2) 334-335
  PubMedGoogle Scholar
• 15 Singhal A B, Topcuoglu M A, Buonanno F S. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study.  Stroke. 2002;  33(5) 1267-1273
  CrossrefPubMedGoogle Scholar
• 16 Lee A Y, Levine M N, Baker R I Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.  N Engl J Med. 2003;  349(2) 146-153
  CrossrefPubMedGoogle Scholar
• 17 de Bruijn S F, Budde M, Teunisse S, de Haan R J, Stam J. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis.  Neurology. 2000;  54(8) 1687-1689
  CrossrefPubMedGoogle Scholar
• 18 Soleau S W, Schmidt R, Stevens S, Osborn A, MacDonald J D. Extensive experience with dural sinus thrombosis.  Neurosurgery. 2003;  52(3) 534-544 discussion 542-544
  PubMedGoogle Scholar
• 19 Klein P, Haley E C, Wooten G F, VandenBerg S R. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases.  Arch Neurol. 1989;  46(10) 1149-1152
  PubMedGoogle Scholar
• 20 Anghel G, Petrinato G, Severino A et al.. Intravascular B-cell lymphoma: report of two cases with different clinical presentation but rapid central nervous system involvement.  Leuk Lymphoma. 2003;  44(8) 1353-1359
  CrossrefPubMedGoogle Scholar
• 21 Herman C, Kupsky W J, Rogers L, Duman R, Moore P. Leptomeningeal dissemination of malignant glioma simulating cerebral vasculitis. Case report with angiographic and pathological studies.  Stroke. 1995;  26(12) 2366-2370
  CrossrefPubMedGoogle Scholar
• 22 Williams R L, Meltzer C C, Smirniotopoulos J G, Fukui M B, Inman M. Cerebral MR imaging in intravascular lymphomatosis.  AJNR Am J Neuroradiol. 1998;  19(3) 427-431
  PubMedGoogle Scholar
• 23 Matsumoto K, Ohta M, Takeshita I. Reversible non-thrombotic occlusion of the superior sagittal sinus caused by metastatic malignant lymphoma—case report.  Neurol Med Chir (Tokyo). 2003;  43(7) 349-351
  CrossrefPubMedGoogle Scholar
• 24 Ponzoni M, Ferreri A JM, Campo E et al.. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.  J Clin Oncol. 2007;  25(21) 3168-3173
  CrossrefPubMedGoogle Scholar
• 25 Lee A Y, Levine M N. The thrombophilic state induced by therapeutic agents in the cancer patient.  Semin Thromb Hemost. 1999;  25(2) 137-145
  Article in Thieme ConnectPubMedGoogle Scholar
• 26 Gugliotta L, Mazzucconi M G, Leone G The GIMEMA Group et al. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study.  Eur J Haematol. 1992;  49(2) 63-66
  CrossrefPubMedGoogle Scholar
• 27 Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Böhles H. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.  J Pediatr Hematol Oncol. 2003;  25(6) 484-487
  CrossrefPubMedGoogle Scholar
• 28 Steele S R, Martin M J, Mullenix P S, Crawford J V, Cuadrado D S, Andersen C A. Focused high-risk population screening for carotid arterial stenosis after radiation therapy for head and neck cancer.  Am J Surg. 2004;  187(5) 594-598
  CrossrefPubMedGoogle Scholar
• 29 Li S H, Chen W H, Tang Y et al.. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients.  Clin Neurol Neurosurg. 2006;  108(2) 150-156
  CrossrefPubMedGoogle Scholar
• 30 Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C. Increased incidence of stroke in women with breast cancer.  Eur J Cancer. 2005;  41(3) 423-429
  CrossrefPubMedGoogle Scholar
• 31 Pritchard K I, Paterson A H, Paul N A, Zee B, Fine S, Pater J. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  J Clin Oncol. 1996;  14(10) 2731-2737
  CrossrefPubMedGoogle Scholar
• 32 Bushnell C D, Goldstein L B. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis.  Neurology. 2004;  63(7) 1230-1233
  CrossrefPubMedGoogle Scholar
• 33 Geiger A M, Fischberg G M, Chen W, Bernstein L. Stroke risk and tamoxifen therapy for breast cancer.  J Natl Cancer Inst. 2004;  96(20) 1528-1536
  PubMedGoogle Scholar
• 34 Cuzick J, Forbes J F, Sestak I International Breast Cancer Intervention Study I Investigators et al. Long-term results of tamoxifen prophylaxis for breast cancer—96-month follow-up of the randomized IBIS-I trial.  J Natl Cancer Inst. 2007;  99(4) 272-282
  PubMedGoogle Scholar
• 35 Bowers D C, McNeil D E, Liu Y et al.. Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study.  J Clin Oncol. 2005;  23(27) 6508-6515
  CrossrefPubMedGoogle Scholar
• 36 De Bruin M L, Dorresteijn L D, van't Veer M B et al.. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.  J Natl Cancer Inst. 2009;  101(13) 928-937
  PubMedGoogle Scholar
• 37 Kikuchi A, Maeda M, Hanada R Tokyo Children's Cancer Study Group (TCCSG) et al. Moyamoya syndrome following childhood acute lymphoblastic leukemia.  Pediatr Blood Cancer. 2007;  48(3) 268-272
  CrossrefPubMedGoogle Scholar
• 38 Ito Y, Arahata Y, Goto Y et al.. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.  AJNR Am J Neuroradiol. 1998;  19(3) 415-417
  PubMedGoogle Scholar
• 39 Marcel M, Leys D, Mounier-Vehier F et al.. Clinical outcome in patients with high-grade internal carotid artery stenosis after irradiation.  Neurology. 2005;  65(6) 959-961
  CrossrefPubMedGoogle Scholar
• 40 Cheng S WK, Wu L LH, Ting A CW, Lau H, Lam L K, Wei W I. Irradiation-induced extracranial carotid stenosis in patients with head and neck malignancies.  Am J Surg. 1999;  178(4) 323-328
  CrossrefPubMedGoogle Scholar
• 41 Kashyap V S, Moore W S, Quinones-Baldrich W J, Baldrich W J. Carotid artery repair for radiation-associated atherosclerosis is a safe and durable procedure.  J Vasc Surg. 1999;  29(1) 90-96 discussion 97-99
  CrossrefPubMedGoogle Scholar
• 42 Lesèche G, Castier Y, Chataigner O et al.. Carotid artery revascularization through a radiated field.  J Vasc Surg. 2003;  38(2) 244-250
  CrossrefPubMedGoogle Scholar
• 43 O'Neill B P, Dinapoli R P, Okazaki H. Cerebral infarction as a result of tumor emboli.  Cancer. 1987;  60(1) 90-95
  CrossrefPubMedGoogle Scholar
• 44 Lefkovitz N W, Roessmann U, Kori S H. Major cerebral infarction from tumor embolus.  Stroke. 1986;  17(3) 555-557
  CrossrefPubMedGoogle Scholar
• 45 Murata J, Sawamura Y, Takahashi A, Abe H, Saitoh H. Intracerebral hemorrhage caused by a neoplastic aneurysm from small-cell lung carcinoma: case report.  Neurosurgery. 1993;  32(1) 124-126
  CrossrefPubMedGoogle Scholar
• 46 Pickering L, Cox I, Pandha H. Left atrial sarcoma presenting as cerebral infarction.  Lancet Oncol. 2001;  2(11) 705-706
  CrossrefPubMedGoogle Scholar
• 47 Urrutia V, Jichici D, Thomas C E, Nunes L W, Schwartzman R J. Embolic stroke secondary to an aortic arch tumor—a case report.  Angiology. 2000;  51(11) 959-962
  CrossrefPubMedGoogle Scholar
• 48 Brown D V, Faber L P, Tuman K J. Perioperative stroke caused by arterial tumor embolism.  Anesth Analg. 2004;  98(3) 806-809
  PubMedGoogle Scholar
• 49 Coplin W M, Cochran M S, Levine S R, Crawford S W. Stroke after bone marrow transplantation: frequency, aetiology and outcome.  Brain. 2001;  124(Pt 5) 1043-1051
  CrossrefPubMedGoogle Scholar
• 50 Kawanami T, Kurita K, Yamakawa M, Omoto E, Kato T. Cerebrovascular disease in acute leukemia: a clinicopathological study of 14 patients.  Intern Med. 2002;  41(12) 1130-1134
  CrossrefPubMedGoogle Scholar
• 51 Walsh T J, Hier D B, Caplan L R. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.  Ann Neurol. 1985;  18(5) 574-582
  CrossrefPubMedGoogle Scholar
• 52 Gabelmann A, Klein S, Kern W et al.. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients.  Eur J Neurol. 2007;  14 548-555
  CrossrefPubMedGoogle Scholar
• 53 Navi B B, Reichman J S, Berlin D et al.. Intracerebral and subarachnoid hemorrhage in patients with cancer.  Neurology. 2010;  74(6) 494-501
  CrossrefPubMedGoogle Scholar
• 54 Antman K H, Skarin A T, Mayer R J, Hargreaves H K, Canellos G P. Microangiopathic hemolytic anemia and cancer: a review.  Medicine (Baltimore). 1979;  58(5) 377-384
  PubMedGoogle Scholar
• 55 Gordon L I, Kwaan H C. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.  Semin Thromb Hemost. 1999;  25(2) 217-221
  Article in Thieme ConnectPubMedGoogle Scholar
• 56 Humphreys B D, Sharman J P, Henderson J M et al.. Gemcitabine-associated thrombotic microangiopathy.  Cancer. 2004;  100(12) 2664-2670
  CrossrefPubMedGoogle Scholar
• 57 Graus F, Saiz A, Sierra J et al.. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study.  Neurology. 1996;  46(4) 1004-1009
  PubMedGoogle Scholar
• 58 Najima Y, Ohashi K, Miyazawa M et al.. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.  Am J Hematol. 2009;  84(5) 298-301
  CrossrefPubMedGoogle Scholar
• 59 Pitner S E, Johnson W W. Chronic subdural hematoma in childhood acute leukemia.  Cancer. 1973;  32(1) 185-190
  CrossrefPubMedGoogle Scholar
• 60 Jourdan E, Dombret H, Glaisner S, Micléa J M, Castaigne S, Degos L. Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component.  Br J Haematol. 1995;  89(3) 527-530
  CrossrefPubMedGoogle Scholar
• 61 Lengfelder E, Saussele S, Weisser A, Büchner T, Hehlmann R. Treatment concepts of acute promyelocytic leukemia.  Crit Rev Oncol Hematol. 2005;  56(2) 261-274
  CrossrefPubMedGoogle Scholar
• 62 Colosimo M, McCarthy N, Jayasinghe R, Morton J, Taylor K, Durrant S. Diagnosis and management of subdural haematoma complicating bone marrow transplantation.  Bone Marrow Transplant. 2000;  25(5) 549-552
  CrossrefPubMedGoogle Scholar
• 63 Lieu A S, Hwang S L, Howng S L, Chai C Y. Brain tumors with hemorrhage.  J Formos Med Assoc. 1999;  98(5) 365-367
  PubMedGoogle Scholar
• 64 Minette S E, Kimmel D W. Subdural hematoma in patients with systemic cancer.  Mayo Clin Proc. 1989;  64(6) 637-642
  PubMedGoogle Scholar
• 65 McIver J I, Scheithauer B W, Rydberg C H, Atkinson J LD. Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report.  Neurosurgery. 2001;  49(2) 447-449
  CrossrefPubMedGoogle Scholar
• 66 Würthner J U, Köhler G, Behringer D, Lindemann A, Mertelsmann R, Lübbert M. Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis: a clinicopathologic report of four cases.  Cancer. 1999;  85(2) 368-374
  CrossrefPubMedGoogle Scholar
• 67 Nowacki P, Fryze C, Zdziarska B, Zyluk B, Grzelec H, Dudzik T. Central nervous system leukostasis in patients with leukemias and lymphomas.  Folia Neuropathol. 1995;  33(1) 59-65
  PubMedGoogle Scholar
• 68 McKenzie C R, Rengachary S S, McGregor D H, Dixon A Y, Suskind D L. Subdural hematoma associated with metastatic neoplasms.  Neurosurgery. 1990;  27(4) 619-624 discussion 624-625
  CrossrefPubMedGoogle Scholar
• 69 Bromberg J E, Vandertop W P, Jansen G H. Recurrent subdural haematoma as the primary and sole manifestation of chronic lymphocytic leukaemia.  Br J Neurosurg. 1998;  12(4) 373-376
  CrossrefPubMedGoogle Scholar
• 70 Atlas S W, Grossman R I, Gomori J M et al.. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging.  Radiology. 1987;  164(1) 71-77
  PubMedGoogle Scholar
• 71 Bug G, Anargyrou K, Tonn T et al.. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.  Transfusion. 2007;  47(10) 1843-1850
  CrossrefPubMedGoogle Scholar
• 72 Chang M C, Chen T Y, Tang J L et al.. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage.  Am J Hematol. 2007;  82(11) 976-980
  CrossrefPubMedGoogle Scholar

Lisa R RogersD.O. 

Department of Neurology, Medical Director, Neuro-Oncology Program, University Hospitals Case Medical Center, Neurological Institute

11100 Euclid Avenue, Hanna House Room 506, Cleveland, OH 44106

Email: Lisa.Rogers1@UHhospitals.org